You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
9 October 2026 - Medical device company Urolution Medical Inc announced on Friday that it has received US Food and Drug Administration (FDA) 510(k) clearance for its OpenFlo Urinary Catheter, advancing the company toward clinical evaluation and comme...
9 October 2026 - Cell-free DNA and precision medicine company Natera Inc (NASDAQ:NTRA) announced on Friday that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its multi-cancer early detection (MCED) assay, su...
9 October 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Friday that the US Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab ...
9 October 2026 - Clinical-stage biotechnology company Alpheus Medical Inc announced on Thursday the launch of a new clinical trial evaluating its investigational Porphyrin Metabolite Activation (PoMA) therapy in patients with butterfly glioblastoma (...
9 October 2026 - Sophos IRB Inc, an independent, oncology-focused central institutional review board, announced on Thursday a strategic partnership with the Addario Lung Cancer Medical Institute (ALCMI), an international nonprofit specialising in inv...
9 October 2026 - Northwest Biotherapeutics (NWBio) (OTCQB:NWBO), a biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, announced on Thursday a collaboration with the UK National Health Service Blood and Tran...
8 October 2026 - European immunology company argenx SE (EBR & NASDAQ: ARGX) on Thursday reported positive top-line results from a Phase 2 study of FB102, a first-in-class CD122 inhibitor, in adults with coeliac disease.FB102 achieved a statistica...